Excisional lipectomy for HIV-associated cervicodorsal lipodystrophy.
Abstract
[BACKGROUND] The development of effective antiretroviral therapy for the treatment of human immunodeficiency virus (HIV) has allowed for prolonged and healthier lives for affected patients. However, significant side effects from the drugs have been well documented, including syndromes of abnormal fat distribution. Cervicodorsal lipodystrophy, or "buffalo hump" deformity, is a common presentation of lipodystrophy syndrome and can cause significant disfigurement to the patient. Surgical correction has been the mainstay of treatment.
[OBJECTIVE] The authors report on the use of excisional lipectomy to correct cervicodorsal lipodystrophy.
[METHODS] Six male patients and one female patient (mean age, 47.2 years) underwent excisional lipectomy for buffalo hump deformity caused by HIV protease inhibitor use. Common complaints on presentation included disfigurement, neck pain, and difficulty sleeping. Deformity had first been observed an average of 4.75 years before presentation (range 2 to 7 years). At the time of consultation all patients were on antiretroviral regimens that included protease inhibitors.
[RESULTS] Excisional lipectomy of the hypertrophied cervicodorsal fat pad was performed on all patients, with suction-assisted lipoplasty (SAL) additionally to optimally contour the nondystrophic fat at the periphery of the resection. One patient also underwent simultaneous abdominoplasty, another underwent rhytidectomy with autologous fat transfer, and one patient received malar autologous fat injections. The average operative time for all procedures was 2.7 hours (range 1.0 to 5.8 hours). Complications included seroma in three cases and wound dehiscence in one patient, none of which required reoperation. At an average of 26.6 months of follow-up, all patients report satisfaction with their results, and there have been no recurrences.
[CONCLUSIONS] Cervicodorsal lipodystrophy is a well-described complication of extended use of HIV protease inhibitor therapy. Patients may seek consultation with plastic and reconstructive surgeons for correction of the aesthetic and functional morbidity associated with the deformity. Because of the fibrous nature of the hypertrophied cervicodorsal fat and the high rate of recurrence after SAL alone, an approach with excisional lipectomy (with or without SAL) may provide improved results and superior long-term outcomes.
[OBJECTIVE] The authors report on the use of excisional lipectomy to correct cervicodorsal lipodystrophy.
[METHODS] Six male patients and one female patient (mean age, 47.2 years) underwent excisional lipectomy for buffalo hump deformity caused by HIV protease inhibitor use. Common complaints on presentation included disfigurement, neck pain, and difficulty sleeping. Deformity had first been observed an average of 4.75 years before presentation (range 2 to 7 years). At the time of consultation all patients were on antiretroviral regimens that included protease inhibitors.
[RESULTS] Excisional lipectomy of the hypertrophied cervicodorsal fat pad was performed on all patients, with suction-assisted lipoplasty (SAL) additionally to optimally contour the nondystrophic fat at the periphery of the resection. One patient also underwent simultaneous abdominoplasty, another underwent rhytidectomy with autologous fat transfer, and one patient received malar autologous fat injections. The average operative time for all procedures was 2.7 hours (range 1.0 to 5.8 hours). Complications included seroma in three cases and wound dehiscence in one patient, none of which required reoperation. At an average of 26.6 months of follow-up, all patients report satisfaction with their results, and there have been no recurrences.
[CONCLUSIONS] Cervicodorsal lipodystrophy is a well-described complication of extended use of HIV protease inhibitor therapy. Patients may seek consultation with plastic and reconstructive surgeons for correction of the aesthetic and functional morbidity associated with the deformity. Because of the fibrous nature of the hypertrophied cervicodorsal fat and the high rate of recurrence after SAL alone, an approach with excisional lipectomy (with or without SAL) may provide improved results and superior long-term outcomes.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | sal
|
지방흡입 | dict | 3 | |
| 시술 | rhytidectomy
|
안면거상술 | dict | 1 | |
| 시술 | lipoplasty
|
지방흡입 | dict | 1 | |
| 시술 | abdominoplasty
|
복부성형술 | dict | 1 | |
| 해부 | lipectomy
|
scispacy | 1 | ||
| 해부 | cervicodorsal
|
scispacy | 1 | ||
| 해부 | fat
|
scispacy | 1 | ||
| 해부 | malar
|
광대뼈 | dict | 1 | |
| 합병증 | excisional lipectomy
|
scispacy | 1 | ||
| 합병증 | wound
|
scispacy | 1 | ||
| 합병증 | seroma
|
장액종 | dict | 1 | |
| 합병증 | wound dehiscence
|
상처열개 | dict | 1 | |
| 약물 | [BACKGROUND] The
|
scispacy | 1 | ||
| 약물 | [OBJECTIVE]
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS] Cervicodorsal
|
scispacy | 1 | ||
| 질환 | HIV-associated cervicodorsal lipodystrophy
|
scispacy | 1 | ||
| 질환 | human immunodeficiency virus (HIV) has allowed for prolonged and healthier lives for affected patients.
|
scispacy | 1 | ||
| 질환 | Cervicodorsal lipodystrophy
|
scispacy | 1 | ||
| 질환 | lipodystrophy syndrome
|
C1136321
HIV-Associated Lipodystrophy Syndrome
|
scispacy | 1 | |
| 질환 | hump deformity
|
scispacy | 1 | ||
| 질환 | pain
|
C0030193
Pain
|
scispacy | 1 | |
| 질환 | nondystrophic
|
scispacy | 1 | ||
| 질환 | fibrous
|
C0439709
Fibrous
|
scispacy | 1 | |
| 기타 | human immunodeficiency virus
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | buffalo
|
scispacy | 1 | ||
| 기타 | patient
|
scispacy | 1 | ||
| 기타 | HIV protease
|
scispacy | 1 |
MeSH Terms
Adult; Female; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Lipectomy; Male; Middle Aged; Neck; Retrospective Studies
📑 인용 관계
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Implications of Dermatologic Disorders in Facial Cosmetic Surgery: A Systematic Review.
- Clinical safety of a low-modification hyaluronic acid filler (MoD 2%) for facial rejuvenation.
- Case report of a rare soft tissue tuberculosis in a patient undergoing lipoabdominoplasty.
- What is the potential role of the nonopioid suzetrigine in pain management?
- Clinical outcomes of synthetic absorbable mesh use in breast surgery: First case series in reconstruction and aesthetic mastopexy.